Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCL.
Journal: Blood advances
Published: May 13, 2025
Outcomes of patients with relapsed/refractory lymphoplasmacytic lymphoma/waldenström macroglobulinemia treated with venetoclax: a multicenter retrospective analysis.
Journal: Blood cancer journal
Published: January 31, 2025
Cellular Composition and 5hmC Signature Predict the Treatment Response of AML Patients to Azacitidine Combined with Chemotherapy.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: January 19, 2023
Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapy.
Journal: Haematologica
Published: November 11, 2022
Follicular Lymphoma: a Focus on Current and Emerging Therapies
Journal: Oncology (Williston Park, N.Y.)
Published: February 18, 2022
Cedazuridine/decitabine: from preclinical to clinical development in myeloid malignancies.
Journal: Blood advances
Published: December 09, 2020
CDK1 is up-regulated by temozolomide in an NF-κB dependent manner in glioblastoma.
Journal: Scientific reports
Published: May 30, 2020
Clinical outcomes of IDH2-mutated advanced-phase Ph-negative myeloproliferative neoplasms treated with enasidenib.
Journal: British journal of haematology
Published: March 11, 2020
A multi-institutional comparison of mitoxantrone, etoposide, and cytarabine vs high-dose cytarabine and mitoxantrone therapy for patients with relapsed or refractory acute myeloid leukemia.
Journal: American journal of hematology
Published: December 15, 2019
Refining patient selection for CAR T-cell therapy in aggressive large B-cell lymphoma.
Journal: Leukemia & lymphoma
Published: November 22, 2019
Last Updated: 09/26/2026